公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2018 | Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan | Wang, CK; MING-CHIH HO ; Su C.-W.; Wang T.-E.; Dai C.-Y.; CHIEN-HUNG CHEN ; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; PO-HUANG LEE ; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Lin S.-M.; GUAN-TARN HUANG ; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; PO-CHIN LIANG ; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; ANN-LII CHENG ; CHIUN HSU ; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; CHIA-HSIEN CHENG ; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; YEN-HSUAN NI ; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group; Surveillance group; Diagnosis group; Staging group; Surgery group; TACE/TARE/HAI group; Target therapy/systemic therapy group; Radiotherapy group; Prevention group; Drafting group | Journal of the Formosan Medical Association = Taiwan yi zhi | 90 | 87 | |
2021 | Mitigating the impact of COVID-19 on colorectal cancer screening: Organized service screening perspectives from the Asia-Pacific region | HAN-MO CHIU ; Su C.-W.; WEN-FENG HSU ; Jen G.H.-H.; Hsu C.-Y.; Chen S.L.-S.; Chen, Tony Hsiu Hsi | Preventive Medicine | 11 | 12 | |
2015 | A novel application of real-time RT-LAMP for body fluid identification: using HBB detection as the model | Su C.-W.; Li C.-Y.; JAMES CHUN-I LEE ; Ji D.-D.; Li S.-Y.; Daniel B.; Syndercombe-Court D.; Linacre A.; Hsieh H.-M. | Forensic Science, Medicine, and Pathology | 20 | 18 | |
2016 | Novel identification of biofluids using a multiplex methylation sensitive restriction enzyme-PCR system | Lin Y.-C.; Tsai L.-C.; JAMES CHUN-I LEE ; Su C.-W.; Tzen J.T.-C.; Linacre A.; Hsieh H.-M. | Forensic Science International: Genetics | 21 | 18 | |
2015 | A prediction model for periodontal disease: Modelling and validation from a National Survey of 4061 Taiwanese adults | Lai H.; Su C.-W.; Yen A.M.-F.; Chiu S.Y.-H.; Fann J.C.-Y.; Wu W.Y.-Y.; Chuang S.-L.; Liu H.-C.; Chen, Tony Hsiu Hsi ; Chen L.-S. | Journal of Clinical Periodontology | 25 | 24 | |
2015 | Rapid prediction of treatment futility of boceprevir with peginterferon-ribavirin for Taiwanese treatment experienced hepatitis C virus genotype 1-infected patients | Yang C.-C.; Tsai W.-L.; Su W.-W.; Huang C.-F.; Cheng P.-N.; Lo C.-C.; Tseng K.-C.; Mo L.-R.; Wang C.-H.; SHIH-JER HSU ; Lai H.-C.; Su C.-W.; CHUN-JEN LIU ; Peng C.-Y.; Yu M.-L. | PLoS ONE | 8 | 5 | |
2017 | Receiver operating characteristic curve-based prediction model for periodontal disease updated with the calibrated community periodontal index | Su C.-W.; Yen A.M.-F.; Lai H.; Chen, Tony Hsiu Hsi ; Chen S.L.-S. | Journal of Periodontology | 4 | 4 | |
2019 | Risk for a second primary hypopharyngeal and esophageal cancer after an initial primary oral cancer | Su W.W.-Y.; Chuang S.-L.; Yen A.M.-F.; Chen S.L.-S.; Fann J.C.-Y.; Chiu S.Y.-H.; HAN-MO CHIU ; Su C.-W.; Hsu C.-Y.; Chen M.-K.; Chen, Tony Hsiu Hsi ; CHENG-PING WANG ; YI-CHIA LEE | Oral Diseases | 5 | 5 | |
2020 | Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B | Huang Y.-W.; Hsu C.-W.; Lu S.-N.; Yu M.-L.; Su C.-W.; Su W.-W.; Chien R.-N.; Hsu C.-S.; SHIH-JER HSU ; Lai H.-C.; Qin A.; Tseng K.-C.; PEI-JER CHEN | Hepatology International | 18 | 14 | |